US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

66.95

-0.8350-1.23%

Volume:216.32K

Turnover:14.66M

Market Cap:4.57B

PE:-15.35

High:68.65

Open:67.49

Low:66.00

Close:67.78

52wk High:84.56

52wk Low:26.20

Shares:68.32M

Float Shares:47.47M

Volume Ratio:1.94

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3614

EPS(LYR):-3.3001

ROE:-38.41%

ROA:-25.26%

PB:7.80

PE(LYR):-20.29

Loading ...

Overview Company News Filings

Assessing Apogee Therapeutics (APGE) Valuation After Recent Share Price Volatility

Simply Wall St.

Apogee Therapeutics CEO Michael Henderson Reports Sale of Common Shares

Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares

Apogee Therapeutics CFO Jane Henderson Reports Sale of Common Shares

BTIG Sticks to Its Buy Rating for Apogee Therapeutics (APGE)

Apogee Therapeutics Inc : Jefferies Cuts Target Price to $95 From $98

THOMSON REUTERS

13D Filings -- Barrons.com

Analysts Are Bullish on These Healthcare Stocks: Concentra Group Holdings Parent, Inc. (CON), Apogee Therapeutics (APGE)

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), GE Healthcare Technologies Inc (GEHC) and Apogee Therapeutics (APGE)

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Sanofi (OtherSNYNF)

Apogee selloff on Sanofi data brings opportunity, says UBS

Apogee Therapeutics selloff on Sanofi data overdone, says Citi

Apogee Therapeutics Falls on Investor Sells Shares Worth $133.5M

Fairmount Funds Management Reports Disposal of Apogee Therapeutics Common Shares

Apogee Therapeutics' Lead Drug Shows Promise, but Valuation has Reached Near-Term Peak, RBC Says

MT Newswires Live

Apogee Therapeutics Cut to Sector Perform From Outperform by RBC Capital

RBC Downgrades Apogee Therapeutics to Sector Perform From Outperform, Raises Price Target to $83 From $70, Keeps Speculative Risk

MT Newswires Live

Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and GoodRx Holdings (GDRX)

Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/APGE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":66.945,"timestamp":1771341169705,"preClose":67.78,"halted":0,"volume":216318,"delay":0,"changeRate":-0.012319268220714193,"floatShares":47471600,"shares":68320200,"eps":-4.361393,"marketStatus":"Trading","change":-0.835,"latestTime":"02-17 10:12:53 EST","open":67.49,"high":68.65,"low":66,"amount":14657895.876659999,"amplitude":0.039097,"askPrice":66.76,"askSize":26,"bidPrice":66.53,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-4.361393,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771362000000},"marketStatusCode":2,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":67.78,"preHourTrading":{"tag":"盘前","latestPrice":67.01,"preClose":67.78,"latestTime":"09:20 EST","volume":14,"amount":957.52006,"timestamp":1771338017925,"change":-0.77,"changeRate":-0.01136,"amplitude":0.02936},"postHourTrading":{"tag":"盘后","latestPrice":67.1,"preClose":67.78,"latestTime":"18:31 EST","volume":17005,"amount":1152535.82,"timestamp":1771025466489,"change":-0.68,"changeRate":-0.010032,"amplitude":0.017704},"volumeRatio":1.943419,"impliedVol":1.0392,"impliedVolPercentile":0.8526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":47471600,"roa":"-25.26%","roe":"-38.41%","lyrEps":-3.300106,"volumeRatio":1.943419,"shares":68320200,"dividePrice":0,"high":68.65,"amplitude":0.039097,"preClose":67.78,"low":66,"week52Low":26.2,"pbRate":"7.80","week52High":84.56,"institutionHeld":0,"latestPrice":66.945,"committee":-0.925926,"eps":-4.361393,"divideRate":0,"volume":216318,"delay":0,"ttmEps":-4.361393,"open":67.49,"prevYearClose":75.48,"prevWeekClose":67.78,"prevMonthClose":65.51,"prevQuarterClose":75.48,"fiveDayClose":62.13,"twentyDayClose":80.77,"sixtyDayClose":63.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"APGE","fiscalQuarterEnding":"2025/09","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.11},{"market":"US","date":"2025-08-11","symbol":"APGE","fiscalQuarterEnding":"2025/06","expectedEps":-1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.13},{"market":"US","date":"2025-05-12","symbol":"APGE","fiscalQuarterEnding":"2025/03","expectedEps":-1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-03-03","symbol":"APGE","fiscalQuarterEnding":"2024/12","expectedEps":-0.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-1.19},{"market":"US","date":"2024-11-12","symbol":"APGE","fiscalQuarterEnding":"2024/09","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":16,"updateTime":1769317200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2026-02-13","current":-15.540906,"percent":0.460064,"low":-42.099968,"twenty":-25.257004,"median":-17.587319,"eighty":-11.943328,"high":-8.51736,"avg":-19.120724,"sd":7.660068,"marketCap":4677609914},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600},{"date":"2025-06-13","current":-11.895942,"twenty":-26.656227,"median":-20.052494,"eighty":-12.887608,"marketCap":2443319391},{"date":"2025-06-20","current":-11.702697,"twenty":-26.554695,"median":-19.987224,"eighty":-12.832982,"marketCap":2403628584},{"date":"2025-06-27","current":-12.450101,"twenty":-26.451682,"median":-19.588347,"eighty":-12.738391,"marketCap":2557138617},{"date":"2025-07-03","current":-13.487372,"twenty":-26.404333,"median":-19.162534,"eighty":-12.723904,"marketCap":2770184861},{"date":"2025-07-11","current":-10.960977,"twenty":-26.318444,"median":-18.921984,"eighty":-12.668332,"marketCap":2251285927},{"date":"2025-07-18","current":-11.083176,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"marketCap":2276384526},{"date":"2025-07-25","current":-11.833421,"twenty":-26.172746,"median":-18.534,"eighty":-12.51704,"marketCap":2430478247},{"date":"2025-08-01","current":-10.872879,"twenty":-26.165436,"median":-18.435064,"eighty":-12.454858,"marketCap":2233191588},{"date":"2025-08-08","current":-10.230624,"twenty":-26.144692,"median":-18.356106,"eighty":-12.348931,"marketCap":2101278024},{"date":"2025-08-15","current":-9.370325,"twenty":-26.131061,"median":-18.310909,"eighty":-12.239332,"marketCap":2227054492},{"date":"2025-08-22","current":-8.957767,"twenty":-26.099427,"median":-18.29345,"eighty":-12.125473,"marketCap":2129001470},{"date":"2025-08-29","current":-9.024303,"twenty":-26.061716,"median":-18.235984,"eighty":-12.057962,"marketCap":2144815236},{"date":"2025-09-05","current":-9.149983,"twenty":-26.050112,"median":-18.048125,"eighty":-11.971712,"marketCap":2174685683},{"date":"2025-09-12","current":-9.184484,"twenty":-25.999346,"median":-17.978348,"eighty":-11.914309,"marketCap":2182885414},{"date":"2025-09-19","current":-9.470344,"twenty":-25.989488,"median":-17.837569,"eighty":-11.833421,"marketCap":2250826038},{"date":"2025-09-26","current":-9.246091,"twenty":-25.963085,"median":-17.587319,"eighty":-11.751667,"marketCap":2197527790},{"date":"2025-10-03","current":-9.761132,"twenty":-25.927394,"median":-17.537558,"eighty":-11.64586,"marketCap":2319938053},{"date":"2025-10-10","current":-13.112594,"twenty":-25.927394,"median":-17.474803,"eighty":-11.60039,"marketCap":3116483307},{"date":"2025-10-17","current":-14.719201,"twenty":-25.919571,"median":-17.381927,"eighty":-11.6264,"marketCap":3498327236},{"date":"2025-10-24","current":-14.83497,"twenty":-25.825784,"median":-17.31961,"eighty":-11.641401,"marketCap":3525842169},{"date":"2025-10-31","current":-15.446892,"twenty":-25.767274,"median":-17.151542,"eighty":-11.64586,"marketCap":3671278245},{"date":"2025-11-07","current":-15.158848,"twenty":-25.763689,"median":-17.013102,"eighty":-11.649617,"marketCap":3602818471},{"date":"2025-11-14","current":-16.75274,"twenty":-25.752769,"median":-16.901067,"eighty":-11.702697,"marketCap":4249734472},{"date":"2025-11-21","current":-16.859157,"twenty":-25.643182,"median":-16.952708,"eighty":-11.751008,"marketCap":4276729768},{"date":"2025-11-28","current":-19.147128,"twenty":-25.58,"median":-17.00282,"eighty":-11.751535,"marketCap":4857128632},{"date":"2025-12-05","current":-20.086261,"twenty":-25.516057,"median":-17.081704,"eighty":-11.751783,"marketCap":5095362120},{"date":"2025-12-12","current":-20.360285,"twenty":-25.476749,"median":-17.24758,"eighty":-11.795704,"marketCap":5164875007},{"date":"2025-12-19","current":-20.578441,"twenty":-25.464129,"median":-17.327965,"eighty":-11.813694,"marketCap":5220215364},{"date":"2025-12-26","current":-20.775313,"twenty":-25.437705,"median":-17.381927,"eighty":-11.826232,"marketCap":5270156661},{"date":"2026-01-02","current":-20.08094,"twenty":-25.407235,"median":-17.443781,"eighty":-11.835695,"marketCap":5094012355},{"date":"2026-01-09","current":-20.613026,"twenty":-25.376631,"median":-17.517481,"eighty":-11.841525,"marketCap":5228988835},{"date":"2026-01-16","current":-21.482988,"twenty":-25.344147,"median":-17.566657,"eighty":-11.865469,"marketCap":5449675380},{"date":"2026-01-23","current":-21.246209,"twenty":-25.316184,"median":-17.607671,"eighty":-11.899615,"marketCap":5389610846},{"date":"2026-01-30","current":-18.617702,"twenty":-25.310382,"median":-17.773551,"eighty":-11.916319,"marketCap":4722827035},{"date":"2026-02-06","current":-16.529263,"twenty":-25.299938,"median":-17.629714,"eighty":-11.92777,"marketCap":4193044351},{"date":"2026-02-13","current":-18.439453,"twenty":-25.257004,"median":-17.587319,"eighty":-11.943328,"marketCap":4677609914}],"updateTime":1771315816747},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612435884","title":"Assessing Apogee Therapeutics (APGE) Valuation After Recent Share Price Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2612435884","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612435884?lang=en_us&edition=fundamental","pubTime":"2026-02-17 08:28","pubTimestamp":1771288094,"startTime":"0","endTime":"0","summary":"Why Apogee Therapeutics Is On Investors’ Radar Today\nApogee Therapeutics (APGE) has been drawing attention after sharp moves in its share price in recent weeks, prompting investors to reassess how its clinical stage respiratory and inflammatory disease pipeline lines up with current market expectations.\nSee our latest analysis for Apogee Therapeutics.\nAt a share price of $67.78, Apogee Therapeutics has seen a mix of sharp moves recently, with a 9.1% 7 day share price return, a 16.1% 30 day...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-apge/apogee-therapeutics/news/assessing-apogee-therapeutics-apge-valuation-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-apge/apogee-therapeutics/news/assessing-apogee-therapeutics-apge-valuation-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","APGE","BK4139"],"gpt_icon":0},{"id":"2611519427","title":"Apogee Therapeutics CEO Michael Henderson Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2611519427","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611519427?lang=en_us&edition=fundamental","pubTime":"2026-02-14 09:00","pubTimestamp":1771030859,"startTime":"0","endTime":"0","summary":"Michael Thomas Henderson, Chief Executive Officer and Director of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260214:nNDL7VGSr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CEO Michael Henderson Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"gpt_icon":0},{"id":"2609631010","title":"Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609631010","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609631010?lang=en_us&edition=fundamental","pubTime":"2026-02-05 09:02","pubTimestamp":1770253371,"startTime":"0","endTime":"0","summary":"Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDLblq5gj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","APGE"],"gpt_icon":0},{"id":"2609118310","title":"Apogee Therapeutics CFO Jane Henderson Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609118310","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609118310?lang=en_us&edition=fundamental","pubTime":"2026-02-05 09:01","pubTimestamp":1770253288,"startTime":"0","endTime":"0","summary":"Jane Henderson, Chief Financial Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDLSLjD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CFO Jane Henderson Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","APGE","BK4139"],"gpt_icon":0},{"id":"2608843840","title":"BTIG Sticks to Its Buy Rating for Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608843840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608843840?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:16","pubTimestamp":1770088565,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Apogee Therapeutics, with a price target of $137.00. According...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-its-buy-rating-for-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-its-buy-rating-for-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2608986116","title":"Apogee Therapeutics Inc : Jefferies Cuts Target Price to $95 From $98","url":"https://stock-news.laohu8.com/highlight/detail?id=2608986116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608986116?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:10","pubTimestamp":1770037822,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YY16L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2607020743","title":"13D Filings -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2607020743","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607020743?lang=en_us&edition=fundamental","pubTime":"2026-01-31 08:39","pubTimestamp":1769819940,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Jan. 22 through Jan. 28, 2026. Source: VerityData. Cogent Biosciences  Fairmount Funds Management lowered its stake in the clinical-stage biotechnology company to 16,261,918 shares. Fairmount Funds did so through the sale of 3.5 million Cogent Biosciences shares via a block sale on Jan. 22 at a price of $36.40 per share. Following the latest sale, Fairmount Funds Management continues to own 9.9% of Cogent Biosciences' outstanding stock. Shares of Cogent Biosciences have gaine","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2098885051.SGD","LU2125909916.SGD","BK4185","ACHC","BK4585","BK4588","BK4505","APGE","LU2125909759.SGD","ESTC","BK4613","BK4023","BK4608","LU1923622291.USD","LU0053671581.USD","LU1303367103.USD","ROG","BK4148","BK4139","COGT","LU0054578231.USD"],"gpt_icon":0},{"id":"2607258930","title":"Analysts Are Bullish on These Healthcare Stocks: Concentra Group Holdings Parent, Inc. (CON), Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607258930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607258930?lang=en_us&edition=fundamental","pubTime":"2026-01-31 02:20","pubTimestamp":1769797211,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Concentra Group Holdings Parent, Inc. (CON – Researc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-concentra-group-holdings-parent-inc-con-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-concentra-group-holdings-parent-inc-con-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","BK4139","LU0128526141.USD","BK4185","XBI","CON","BK4585","LABU","BK4581","LU0029874061.USD","LU0053671581.USD","BK4137","BK4588","APGE"],"gpt_icon":0},{"id":"2607230040","title":"Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), GE Healthcare Technologies Inc (GEHC) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607230040","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607230040?lang=en_us&edition=fundamental","pubTime":"2026-01-31 02:10","pubTimestamp":1769796642,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fractyl Health, Inc. (GUTS – Research Report), GE Healthcare Tech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fractyl-health-inc-guts-ge-healthcare-technologies-inc-gehc-and-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fractyl-health-inc-guts-ge-healthcare-technologies-inc-gehc-and-apogee-therapeutics-apge-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4206","LU1119994496.HKD","BK4082","LU1261432733.SGD","XBI","BK4543","LU0149725797.USD","LU0053671581.USD","BK4588","LU0267386448.USD","LU0354030438.USD","LU2168564065.EUR","BK4566","GUTS","LU2168563687.JPY","BK4501","LU2756315318.SGD","LU1551013342.USD","LU0943347566.SGD","LU0124676726.USD","LU1988902786.USD","LU1366333091.USD","LU2168564495.EUR","BK4139","GE","APGE","LU0157215616.USD","LU2264538146.SGD","LU0077335932.USD","LU2756315664.SGD","LU2168564222.USD","BK4585","LU0820562030.AUD","LABU","LU0689626769.HKD","LU1366192091.USD","LU1064131342.USD","GEHC","BK4581","LU0868494617.USD","LU0820561818.USD","LU2168564149.EUR","LU0689472784.USD","LU0820561909.HKD","LU1280957306.USD","LU0640476718.USD","LU0354030511.USD","LU1093756325.SGD","XLV","LU1093756168.USD"],"gpt_icon":0},{"id":"2606268238","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Sanofi (OtherSNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606268238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606268238?lang=en_us&edition=fundamental","pubTime":"2026-01-26 01:00","pubTimestamp":1769360417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apogee Therapeutics (APGE – Research Report) and Sanofi (SNYNF – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-sanofi-othersnynf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-sanofi-othersnynf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","BK4588","LU0053671581.USD","APGE","BK4139","BK4581","SNYNF","XBI","BK4585","LU0029874061.USD","XLV","LABU","HCSG","BK4007"],"gpt_icon":0},{"id":"2606268330","title":"Apogee selloff on Sanofi data brings opportunity, says UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2606268330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606268330?lang=en_us&edition=fundamental","pubTime":"2026-01-26 00:05","pubTimestamp":1769357108,"startTime":"0","endTime":"0","summary":"UBS analyst Michael Yee says Apogee Therapeutics (APGE) sold off Friday following Sanofi’s (SNY) positive Phase III OX40L data in moderate to sever...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-selloff-on-sanofi-data-brings-opportunity-says-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-selloff-on-sanofi-data-brings-opportunity-says-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4118","IE00BFXG1179.USD","LU3187612489.SGD","BK4588","APGE","SNYNF","BK4534","SNY","LU1829250122.USD","UBS","IE0034235071.USD","LU1863844749.USD","LU0053671581.USD","BK4139","BK4007","BK4585","LU1863844665.USD"],"gpt_icon":0},{"id":"2606250025","title":"Apogee Therapeutics selloff on Sanofi data overdone, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2606250025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606250025?lang=en_us&edition=fundamental","pubTime":"2026-01-25 23:50","pubTimestamp":1769356209,"startTime":"0","endTime":"0","summary":"Citi says Friday’s selloff in shares of Apogee Therapeutics (APGE) following Sanofi’s (SNY) Phase 3 amlitelimab data is an overreaction. The firm i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-selloff-on-sanofi-data-overdone-says-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-selloff-on-sanofi-data-overdone-says-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SNYNF","APGE","BK4585","LU0053671581.USD","IE00BFXG1179.USD","BK4139","SNY","BK4007"],"gpt_icon":0},{"id":"2605404003","title":"Apogee Therapeutics Falls on Investor Sells Shares Worth $133.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2605404003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605404003?lang=en_us&edition=fundamental","pubTime":"2026-01-24 01:03","pubTimestamp":1769187780,"startTime":"0","endTime":"0","summary":"Shares of Apogee Therapeutics slid after stakeholder Fairmount Funds Management sold a portion of its holdings for $133.5 million.The stock was down 12% to $69.90 at midday on Friday. Shares have gained 74% in the past 12 months.Fairmount, a Philadelphia-based life sciences and biotech investment firm, sold 1.75 million shares at an average price of $76.30 on Thursday, according to a filing after the market close with the Securities and Exchange Commission.The transaction leaves Fairmount holding roughly 401,000 shares of Apogee, according to the filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","APGE"],"gpt_icon":0},{"id":"2605441578","title":"Fairmount Funds Management Reports Disposal of Apogee Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605441578","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605441578?lang=en_us&edition=fundamental","pubTime":"2026-01-23 09:07","pubTimestamp":1769130471,"startTime":"0","endTime":"0","summary":"Fairmount Funds Management LLC reported a disposal of common shares of Apogee Therapeutics Inc. The Form 4 was filed by more than one reporting person, including Fairmount Funds Management LLC, Tomas Kiselak, and Peter Harwin, among other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nNDL677bm5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Fairmount Funds Management Reports Disposal of Apogee Therapeutics Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"gpt_icon":0},{"id":"2605441873","title":"Apogee Therapeutics' Lead Drug Shows Promise, but Valuation has Reached Near-Term Peak, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2605441873","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605441873?lang=en_us&edition=fundamental","pubTime":"2026-01-22 23:51","pubTimestamp":1769097063,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics'  zumilokibart to treat atopic dermatitis and asthma shows promise, but the company's valuation has reached a near-term peak, RBC Capital Markets said in a Thursday research report.The drug's long half-life and durable STAT6 biomarker inhibition could enable the company to showcase sustained efficacy, while reductions in FeNO, a biomarker of Type 2 inflammation, in asthma patients support its differentiated long-acting potential, according to the note.Apogee remains well-positioned and somewhat de-risked, but the inflammatory and immunology diseases segment the company is engaged with is becoming crowded with existing players, raising the bar for future results, analysts wrote.The brokerage said it downgraded the stock to sector perform from outperform and raised its price target to $83 per share from $70.Price: 80.93, Change: -0.98, Percent Change: -1.20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE","LU0053671581.USD","BK4139","SKIS"],"gpt_icon":0},{"id":"2605741890","title":"Apogee Therapeutics Cut to Sector Perform From Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605741890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605741890?lang=en_us&edition=fundamental","pubTime":"2026-01-22 23:39","pubTimestamp":1769096340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2026 10:39 ET (15:39 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"gpt_icon":0},{"id":"2605498383","title":"RBC Downgrades Apogee Therapeutics to Sector Perform From Outperform, Raises Price Target to $83 From $70, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605498383","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605498383?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:20","pubTimestamp":1769080824,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) has an average rating of buy and mean price target of $104.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"gpt_icon":0},{"id":"2605467662","title":"Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605467662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605467662?lang=en_us&edition=fundamental","pubTime":"2026-01-22 18:20","pubTimestamp":1769077211,"startTime":"0","endTime":"0","summary":"RBC Capital downgraded Apogee Therapeutics (APGE) to Sector Perform from Outperform with a price target of $83, up from $70. The firm cites valuati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-downgraded-to-sector-perform-from-outperform-at-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-downgraded-to-sector-perform-from-outperform-at-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2604823571","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and GoodRx Holdings (GDRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604823571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604823571?lang=en_us&edition=fundamental","pubTime":"2026-01-19 17:40","pubTimestamp":1768815626,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE – Research Report) and G...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-goodrx-holdings-gdrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-goodrx-holdings-gdrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","LU0128526141.USD","BK4167","XLV","BK4137","BK4588","GDRX","BK4585","LU0053671581.USD","BK4139","LABU","BK4581","HCSG","LU0029874061.USD","XBI"],"gpt_icon":0},{"id":"2604910341","title":"Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2604910341","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604910341?lang=en_us&edition=fundamental","pubTime":"2026-01-17 09:00","pubTimestamp":1768611657,"startTime":"0","endTime":"0","summary":"Michael Thomas Henderson, Chief Executive Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260117:nNDL8kqWMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","APGE"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":110,"code":"91000000","status":"200"}]}}